Optimal duration of PET studies with 18F-fluoroethyl-diprenorphine

J Nucl Med. 2005 Dec;46(12):2092-6.

Abstract

The tracer 6-O-(2-(18)F-fluoroethyl)-6-O-desmethyldiprenorphine (18F-FDPN) provides enhanced flexibility to PET studies of the opioidergic system because the label has a longer half-life than the label of 11C-diprenorphine. Here we evaluated the ideal length of PET studies with 18F-FDPN.

Methods: 18F-FDPN binding kinetics were quantified with protocols of different lengths by use of a 1-tissue or a 2-tissue compartment model for different volumes of interest. Furthermore, the effects of scanning duration were assessed by parametric analyses.

Results: A 90-min protocol resulted in less than 10% bias in distribution volume (DV) relative to the full-length protocol. Correlation analyses of the DV estimates for the full-length protocol and the shortened protocols showed good replication of DV estimates for regions with both low and high levels of binding at schedules of up to 90 min.

Conclusion: Data sampling in dynamic 18F-FDPN PET acquisitions should not be shorter than 90 min to maintain reliable estimates of DV.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Brain / pathology
  • Diprenorphine / analogs & derivatives*
  • Diprenorphine / pharmacology
  • Humans
  • Image Processing, Computer-Assisted
  • Kinetics
  • Ligands
  • Male
  • Models, Statistical
  • Positron-Emission Tomography / methods*
  • Radiopharmaceuticals / pharmacology*
  • Regression Analysis
  • Time Factors

Substances

  • 6-O-(2-(18F)fluoroethyl)-6-O-desmethyldiprenorphine
  • Ligands
  • Radiopharmaceuticals
  • Diprenorphine